Liposome encapsulated form of the hydrochloride salt of doxorubicin.
Liposomal delivery improves drug penetration into tumors and decreases doxorubicin clearance and increases the duration of the therapeutic drug effects.
Liposomal formulation decreases cardiac toxicity.